Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.

Satu Koivula; Minna Taskinen; Ping Chen; Harald Holte; Jan Delabie; Marja-Liisa Karjalainen-Lindsberg; Magnus Bjorkholm; Oystein Fluge; Lars Moller Pedersen; Mats Jerkeman; Mikael Eriksson; Sampsa Hautaniemi; Sirpa Leppa

Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.

Satu Koivula, Minna Taskinen, Ping Chen, Harald Holte, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Magnus Bjorkholm, Oystein Fluge, Lars Moller Pedersen, Mats Jerkeman, Mikael Eriksson, Sampsa Hautaniemi, Sirpa Leppa

Forskningsoutput: Tidskriftsbidrag › Mötesabstrakt › Peer review

Originalspråk	engelska
Tidskrift	Blood
Volym	116
Utgåva	21
Sidor (från-till)	1281-1281
Antal sidor	1
ISSN	0006-4971
Status	Publicerad - 19 nov 2010
Evenemang	52nd Annual Meeting of the American-Society-of-Hematology (ASH) - Orlando Varaktighet: 4 dec 2010 → 7 dec 2010

Citera det här

Koivula, S., Taskinen, M., Chen, P., Holte, H., Delabie, J., Karjalainen-Lindsberg, M-L., Bjorkholm, M., Fluge, O., Pedersen, L. M., Jerkeman, M., Eriksson, M., Hautaniemi, S., & Leppa, S. (2010). Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. Blood, 116(21), 1281-1281.

Koivula, Satu ; Taskinen, Minna ; Chen, Ping ; Holte, Harald ; Delabie, Jan ; Karjalainen-Lindsberg, Marja-Liisa ; Bjorkholm, Magnus ; Fluge, Oystein ; Pedersen, Lars Moller ; Jerkeman, Mats ; Eriksson, Mikael ; Hautaniemi, Sampsa ; Leppa, Sirpa. / Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. I: Blood. 2010 ; Vol. 116, Nr. 21. s. 1281-1281.

@article{14916124552444d2814e1b4ef4c3a00e,

title = "Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.",

author = "Satu Koivula and Minna Taskinen and Ping Chen and Harald Holte and Jan Delabie and Marja-Liisa Karjalainen-Lindsberg and Magnus Bjorkholm and Oystein Fluge and Pedersen, {Lars Moller} and Mats Jerkeman and Mikael Eriksson and Sampsa Hautaniemi and Sirpa Leppa",

year = "2010",

month = nov,

day = "19",

language = "English",

volume = "116",

pages = "1281--1281",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "21",

note = "52nd Annual Meeting of the American-Society-of-Hematology (ASH) ; Conference date: 04-12-2010 Through 07-12-2010",

}

Koivula, S, Taskinen, M, Chen, P, Holte, H, Delabie, J, Karjalainen-Lindsberg, M-L, Bjorkholm, M, Fluge, O, Pedersen, LM, Jerkeman, M, Eriksson, M, Hautaniemi, S & Leppa, S 2010, 'Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.', Blood, vol. 116, nr. 21, s. 1281-1281.

Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. / Koivula, Satu; Taskinen, Minna; Chen, Ping; Holte, Harald; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Bjorkholm, Magnus; Fluge, Oystein; Pedersen, Lars Moller; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa ; Leppa, Sirpa.

I: Blood, Vol. 116, Nr. 21, 19.11.2010, s. 1281-1281.

Forskningsoutput: Tidskriftsbidrag › Mötesabstrakt › Peer review

TY - JOUR

T1 - Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.

AU - Koivula, Satu

AU - Taskinen, Minna

AU - Chen, Ping

AU - Holte, Harald

AU - Delabie, Jan

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Bjorkholm, Magnus

AU - Fluge, Oystein

AU - Pedersen, Lars Moller

AU - Jerkeman, Mats

AU - Eriksson, Mikael

AU - Hautaniemi, Sampsa

AU - Leppa, Sirpa

PY - 2010/11/19

Y1 - 2010/11/19

M3 - Meeting Abstract

VL - 116

SP - 1281

EP - 1281

JO - Blood

JF - Blood

SN - 0006-4971

IS - 21

T2 - 52nd Annual Meeting of the American-Society-of-Hematology (ASH)

Y2 - 4 December 2010 through 7 December 2010

ER -

Koivula S, Taskinen M, Chen P, Holte H, Delabie J, Karjalainen-Lindsberg M-L et al. Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. Blood. 2010 nov 19;116(21):1281-1281.